R&D Hurdles and Treatment Cost: Major Restraints on the...

added blog Wellness

2025-12-05 12:18:44 - Translate -

R&D Hurdles and Treatment Cost: Major Restraints on the Widespread Adoption of Novel Therapies in the Osteoarthritis Market Restraints

Despite robust growth drivers, the Osteoarthritis Market Restraints are defined by two persistent issues: the lack of approved Disease-Modifying Osteoarthritis Drugs (DMOADs) and the high cost and complex regulatory pathway for novel biologics and regenerative treatments. 1. Lack of Curative DMOADs: The single most significant restraint is the absence of a widely approved, curative, or truly...

0 Comments 0 Shares 29 Views 0 Reviews